摘要
目的分析抗抑郁药在广东的销售情况和发展趋势。方法通过统计广东75家代表性医院2005-2007年抗抑郁药销售数据,了解抗抑郁药的销售情况,分析各类型抗抑郁药的销售及国内厂家与进口合资厂家药品的销售情况。结果抗抑郁药销售年均增长23.93%,5-羟色胺再摄取抑制剂(SSRIs)约占60%市场份额,进口合资药品约占87%。结论抗抑郁药销售增幅明显,SSRIs为最常用的一类抗抑郁药,国内抗抑郁药市场仍然由进口合资厂家主导,国内制药厂商迎来最好的发展机遇。
Objective To analyse the sales information and the trend of developing of antidepressants in Guangdong province. Methods Based on the statistics of the consumption of antidepressants used in 75 hospitals in Guangdong province during the period 2005-2007, to see the sales information of antidepressants, to analyse the sales information of each kind of antidepressants and the sales information of the medicine produced by internal or overseas manufacturer. Results The sales amount of antidepressants had increased by 23.93% annual average. The selective serotonin reuptake inhibitors（SSRIs） were held almost 60% market share of antidepressants, and the 87% sales amount of the antidepressants had been come from overseas and joint stock manufacturer. Coultmion The sales amount of antidepressants had increased obviously. SSRIs were used most popularly in all kinds of the antidepressants, the internal market of antidepressants were lead by the manufacturers of overseas and joint stock ,and internal manufacturers have a good developing opportunity.
出处
《中国实用医药》
2008年第28期194-196,共3页
China Practical Medicine
关键词
抗抑郁药
销售
市场
分析
Antidepressant
Sales
Market
Analysis
